Apixaban vs Warfarin in Patients With Atrial FibrillationApixaban vs Warfarin in Patients With Atrial Fibrillation
Are the rates of stroke/systemic embolism and major bleeding lower among patients assigned to apixaban -- irrespective of prior vitamin K antagonist use? American Heart Journal
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
More News: Atrial Fibrillation | Bleeding | Cardiology | Coumadin | Health | Heart | Stroke | Vitamins | Warfarin